UTHR
United Therapeutics Corporation Earnings
$359.58
Earnings Summary
Revenue | $748.9Mn |
Net Profits | $309.1Mn |
Net Profit Margins | 41.27% |
United Therapeutics Corporation’s revenue jumped 22.89% since last year same period to $748.9Mn in the Q3 2024. On a quarterly growth basis, United Therapeutics Corporation has generated 4.76% jump in its revenue since last 3-months.
United Therapeutics Corporation’s net profit jumped 15.51% since last year same period to $309.1Mn in the Q3 2024. On a quarterly growth basis, United Therapeutics Corporation has generated 11.15% jump in its net profits since last 3-months.
United Therapeutics Corporation’s net profit margin fell -6.01% since last year same period to 41.27% in the Q3 2024. On a quarterly growth basis, United Therapeutics Corporation has generated 6.1% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the United Therapeutics Corporation post its latest quarter earningsEPS Estimate Current Quarter | 6.43 |
EPS Estimate Current Year | 6.43 |
United Therapeutics Corporation’s earning per share (EPS) estimates for the current quarter stand at 6.43 - a 0.47% jump from last quarter’s estimates.
United Therapeutics Corporation’s earning per share (EPS) estimates for the current year stand at 6.43.
Key Ratios
Key ratios of the United Therapeutics Corporation post its Q3 2024 earningsEarning Per Share (EPS) | 6.39 |
United Therapeutics Corporation’s earning per share (EPS) jumped 18.77% since last year same period to 6.39 in the Q3 2024. This indicates that the United Therapeutics Corporation has generated 18.77% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-05-01 | 5.65 | 6.17 | 9.2% |
2024-07-31 | 6.4 | 5.85 | -8.59% |
2024-10-30 | 6.43 | 6.39 | -0.62% |
₹0 US Stocks a/c Opening Fee